Menu
Currency
GWAS Study

Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations.

Cornejo-García JA, Liou LB, Blanca-López N et al.

24236485 PubMed ID
GWAS Study Type
457 Participants
41 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CJ
Cornejo-García JA
LL
Liou LB
BN
Blanca-López N
DI
Doña I
CC
Chen CH
CY
Chou YC
CH
Chuang HP
WJ
Wu JY
CY
Chen YT
PM
Plaza-Serón Mdel C
MC
Mayorga C
GR
Guéant-Rodríguez RM
LS
Lin SC
TM
Torres MJ
CP
Campo P
RC
Rondón C
LJ
Laguna JJ
FJ
Fernández J
GJ
Guéant JL
CG
Canto G
BM
Blanca M
LM
Lee MT
Chapter II

Abstract

Summary of the research findings

Aim: Acute urticaria/angioedema (AUA) induced by cross-intolerance to NSAIDs is the most frequent clinical entity in hypersensitivity reactions to drugs. In this work, we conducted a genome-wide association study in Spanish and Han Chinese patients suffering from NSAID-induced AUA.

112 European ancestry cases, 124 European ancestry controls, 120 Han Chinese ancestry cases, 101 Han Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

457
Total Participants
GWAS
Study Type
No
Replicated
East Asian, European
Ancestry
China, Spain
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.